Photographic colour material containing a resorcinol derivative as black coupler
    1.
    发明申请
    Photographic colour material containing a resorcinol derivative as black coupler 失效
    含有间苯二酚衍生物作为黑色成色剂的摄影彩色材料

    公开(公告)号:US20060084014A1

    公开(公告)日:2006-04-20

    申请号:US11247960

    申请日:2005-10-11

    CPC classification number: G03C7/346

    Abstract: A colour photographic material is disclosed comprising a black image forming coupler substituted in the 2, 4 and/or 6 position shown by formula (I) or formula (II), where in LINK represents a divalent linking group, BALL represents a group that prevents the coupler from diffusing away from the layer containing it. X and Y each represent a hydrogen atom or a coupling-off group capable of being released upon an oxidative coupling reaction with a developing agent. The material has a good colour reproduction and excellent light stability.

    Abstract translation: 公开了一种彩色照相材料,其包括在式(I)或式(II)所示的2,4和/或6位置取代的黑色成像成色剂,其中LINK表示二价连接基团,BALL表示防止 耦合器从包含它的层扩散。 X和Y各自表示与显影剂的氧化偶联反应时能够释放的氢原子或偶联离子基团。 该材料具有良好的色彩再现性和优异的光稳定性。

    Photographic colour material containing a resorcinol derivative as black coupler
    2.
    发明授权
    Photographic colour material containing a resorcinol derivative as black coupler 失效
    含有间苯二酚衍生物作为黑色成色剂的摄影彩色材料

    公开(公告)号:US07323294B2

    公开(公告)日:2008-01-29

    申请号:US11247960

    申请日:2005-10-11

    CPC classification number: G03C7/346

    Abstract: A color photographic material is disclosed comprising a black image forming coupler substituted in the 2, 4 and/or 6 position shown by formula (I) or formula (II), where in LINK represents a divalent linking group, BALL represents a group that prevents the coupler from diffusing away from the layer containing it. X and Y each represent a hydrogen atom or a coupling-off group capable of being released upon an oxidative coupling reaction with a developing agent. The material has a good color reproduction and excellent light stability.

    Abstract translation: 公开了一种彩色照相材料,其包括在式(I)或式(II)所示的2,4和/或6位置取代的黑色成像成色剂,其中LINK表示二价连接基团,BALL表示防止 耦合器从包含它的层扩散。 X和Y各自表示与显影剂的氧化偶联反应时能够释放的氢原子或偶联离子基团。 该材料具有良好的色彩再现性和优异的光稳定性。

    Process for coating cell-culture support
    4.
    发明授权
    Process for coating cell-culture support 失效
    涂覆细胞培养支持的方法

    公开(公告)号:US07670839B2

    公开(公告)日:2010-03-02

    申请号:US10540167

    申请日:2003-12-23

    CPC classification number: C12N5/0075 C07K14/78 C12N2533/54

    Abstract: The invention relates to a support for culturing cells, in particular to microcarriers coated with gelatine or gelatine-like proteins. Such microcarriers serve as support for culturing anchorage dependent cells. In particular the invention relates to a process for the preparation of a cell culture support comprising the step of coating a microcarrier bead with gelatine or gelatine-like protein, said gelatine or gelatine-like protein having a molecular weight of about 40 kDa to about 200 kDa.

    Abstract translation: 本发明涉及培养细胞的载体,特别涉及用明胶或明胶样蛋白包被的微载体。 这种微载体用作培养依赖于锚定细胞的载体。 特别地,本发明涉及一种制备细胞培养支持物的方法,其包括用明胶或明胶样蛋白包被微载体珠的步骤,所述明胶或明胶样蛋白具有约40kDa至约200的分子量 kDa。

    Silver-dispersing polypeptides
    5.
    发明授权
    Silver-dispersing polypeptides 失效
    银分散多肽

    公开(公告)号:US07179885B2

    公开(公告)日:2007-02-20

    申请号:US10451897

    申请日:2001-12-21

    CPC classification number: C07K14/78 G03C1/0051 G03C1/047

    Abstract: Silver halide emulsions for photographic uses contain a nucleation peptiser having at least one region A of up to 100 amino acids. Region A can either consist of (i) at least two silver-binding amino acids and up to 98 amino acids between the two silver-binding amino acids, or can consist of (ii) a stretch of from 9 to 100 amino acids having a polarity corresponding to an average transfer free energy ΔF equal to or higher than +1.0 kcal/mol. The nucleation peptizer also has at least one region B (separated from region A) having at least 50 amino acids and having a polarity corresponding to an average transfer free energy equal to or lower than −1.0 kcal/mol and not containing methionine residues. The emulsion may also contain a growth peptiser having similar characteristics to the nucleation peptiser, but having a longer A region and a greater overall length.

    Abstract translation: 用于照相用途的卤化银乳剂含有具有至多一个至多100个氨基酸的区域A的成核胶溶剂。 区域A可以由(i)至少两个结合银的氨基酸和两个结合银的氨基酸之间的至多98个氨基酸组成,或者可以由(ii)具有9至100个氨基酸的片段组成,其具有 对应于等于或高于+1.0kcal / mol的平均转移自由能ΔF的极性。 成核胶溶剂还具有至少一个具有至少50个氨基酸并具有对应于等于或低于-1.0kcal / mol的平均转移自由能的极性并且不含有甲硫氨酸残基的至少一个区域B(与区域A分离)。 该乳液还可含有具有与成核胶溶剂相似的特征但具有较长A区和更长总长的生长胶溶剂。

    Method for prevention of platelet aggregation employing and RGD-enriched gelatine-like protein
    6.
    发明授权
    Method for prevention of platelet aggregation employing and RGD-enriched gelatine-like protein 有权
    防止使用富含RGD的明胶样蛋白的血小板聚集的方法

    公开(公告)号:US08080515B2

    公开(公告)日:2011-12-20

    申请号:US12494450

    申请日:2009-06-30

    Abstract: The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.

    Abstract translation: 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。

    RGD-enriched gelatine-like proteins with enhanced cell binding
    7.
    发明授权
    RGD-enriched gelatine-like proteins with enhanced cell binding 有权
    具有增强的细胞结合的RGD富集的明胶样蛋白质

    公开(公告)号:US07671016B2

    公开(公告)日:2010-03-02

    申请号:US11770271

    申请日:2007-06-28

    Abstract: The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.

    Abstract translation: 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。

    Recombinant gelatin-like proteins for use as plasma expanders
    8.
    发明申请
    Recombinant gelatin-like proteins for use as plasma expanders 失效
    用作血浆扩张剂的重组明胶样蛋白

    公开(公告)号:US20050119170A1

    公开(公告)日:2005-06-02

    申请号:US10469747

    申请日:2002-03-06

    Abstract: The invention relates to compositions suitable for plasma substitution comprising as a plasma expander a recombinant gelatin-like protein. Characteristic is that the gelatin-like protein essentially is free of hydroxyproline. This absence of hydroxyproline prevents the composition from gelling and thus allows the use of high-molecular weight proteins in order to establish a suitable colloid osmotic pressure. Specific advantage of the gelatin-like proteins is that these avoid the risk of anaphylactic shock that exists in conjunction with the use of commercially available preparations.

    Abstract translation: 本发明涉及适用于血浆置换的组合物,其包含作为血浆扩张剂的重组明胶样蛋白。 特征是明胶样蛋白质基本上不含羟脯氨酸。 这种羟基脯氨酸的缺乏防止了组合物凝胶化,从而允许使用高分子量蛋白质以建立合适的胶体渗透压。 明胶样蛋白质的具体优点在于,这些避免与使用市售制剂一起存在的过敏性休克的风险。

    Process for preparing a modified polymer
    9.
    发明授权
    Process for preparing a modified polymer 失效
    制备改性聚合物的方法

    公开(公告)号:US06627667B2

    公开(公告)日:2003-09-30

    申请号:US09898723

    申请日:2001-07-03

    CPC classification number: G03C1/053 C08B15/06 C08H1/06 G03C1/04 G03C1/047

    Abstract: The invention is directed to a process for modifying a water soluble polymer, said process comprising modifying a polymer containing amine groups, by reacting at least one of said amine groups with activated ester, said ester being the reaction product of a carboxyl activator and the carboxyl group of a molecule R—COOH, said R-group being a functional group, to produce a reaction mixture containing a polymer, said polymer containing at least one amide group; subjecting said reaction mixture to at least ion exchange chromatography to purify said reaction mixture, said purification comprising at least partly removing the said reaction product, and/or carboxyl activator.

    Abstract translation: 本发明涉及一种改性水溶性聚合物的方法,所述方法包括通过使至少一种所述胺基与活性酯反应来修饰含有胺基团的聚合物,所述酯是羧基活化剂与羧基的反应产物 的分子R-COOH,所述R基团是官能团,以产生含有聚合物的反应混合物,所述聚合物含有至少一个酰胺基团;将所述反应混合物至少进行离子交换色谱以纯化所述反应混合物, 所述纯化包括至少部分除去所述反应产物和/或羧基活化剂。

    Drug delivery system comprising an RGD-enriched gelatine
    10.
    发明授权
    Drug delivery system comprising an RGD-enriched gelatine 有权
    药物递送系统包含富含RGD的明胶

    公开(公告)号:US07645737B2

    公开(公告)日:2010-01-12

    申请号:US11770197

    申请日:2007-06-28

    Abstract: The invention concerns a cell support comprising an RGD-enriched gelatine that has a more even distribution of RGD sequences than occurring in a natural gelatine and with a minimum level of RGD sequences. More precise the percentage of RGD sequences related to the total number of amino acids is at least 0.4 and if the RGD-enriched gelatine comprises 350 amino acids or more, each stretch of 350 amino acids contains at least one RGD motif. Preferably the RGD-enriched gelatines are prepared by recombinant technology, and have a sequence that is derived from a human gelatine or collagen amino acid sequence. The invention also relates to RGD-enriched gelatines that are used for attachment to integrins. In particular The RGD-enriched gelatines of the invention are suitable for coating a cell culture support for growing anchor-dependant cell types. Further, the RGD-enriched gelatines of the invention may find use in medical applications, in particular as a coating on implant or transplant material or as a component of drug delivery systems.

    Abstract translation: 本发明涉及包含富含RGD的明胶的细胞支持物,其具有比在天然明胶中发生的RGD序列更均匀的分布并具有最低水平的RGD序列。 更准确地说,与氨基酸总数相关的RGD序列的百分比至少为0.4,并且如果RGD富集的明胶包含350个氨基酸或更多个,则每个拉伸的350个氨基酸含有至少一个RGD基序。 优选地,通过重组技术制备富含RGD的明胶,并且具有源自人明胶或胶原氨基酸序列的序列。 本发明还涉及用于与整联蛋白连接的RGD富集的明胶。 特别地,本发明的RGD富集的明胶适用于涂覆细胞培养支持物,用于生长锚依赖细胞类型。 此外,本发明的富含RGD的明胶可用于医学应用,特别是作为植入物或移植材料上的涂层或药物递送系统的组分。

Patent Agency Ranking